Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Apr-24 6:10 PM View:  | Contineum Therapeutics, Inc. (CTNM) | 09-Apr-24 | Conversion | 542,628 | -- | -- | 144% 375.54K to 918.16K | |
| 25-Mar-24 4:30 PM View: | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Acquisition (other) | 598,203 | -- | -- | 15% 3.94M to 4.54M | |
| 04-Jan-23 6:11 PM View: | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 2,236,890 | -- | -- | (61%) 3.66M to 1.42M | |
| 04-Jan-23 6:11 PM View: | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition (change in control) | 1,420,730 | -- | -- | (100%) 1.42M to 0 | |
| 11-Aug-22 4:55 PM View: | Century Therapeutics, Inc. (IPSC) | 09-Aug-22 | Disposition (other) | 364,800 | -- | -- | (3%) 13.08M to 12.72M | |
| 11-Aug-22 4:55 PM View: | Century Therapeutics, Inc. (IPSC) | 09-Aug-22 | Sale (Planned) | 550,000 | $13.03 | $7,166,610.00 | (4%) 12.72M to 12.17M | |
| 02-Feb-22 4:31 PM View: | Century Therapeutics, Inc. (IPSC) | 31-Jan-22 | Disposition (other) | 178,996 | -- | -- | (1%) 13.26M to 13.08M | |
| 07-Jan-22 4:20 PM View: | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Acquisition (other) Duplicate | 51,556 | -- | -- | 1% 3.86M to 3.91M | |
| 07-Jan-22 4:20 PM View: | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Disposition (other) Duplicate | 51,556 | -- | -- | (1%) 3.91M to 3.86M | |
| 07-Jan-22 4:20 PM View: | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Disposition (other) Duplicate | 201,474 | -- | -- | (5%) 3.86M to 3.66M | |
| 28-Dec-21 4:46 PM View: | Century Therapeutics, Inc. (IPSC) | 23-Dec-21 | Disposition (other) | 371,004 | -- | -- | (3%) 13.63M to 13.26M | |
| 23-Dec-21 4:40 PM View: | Oyster Point Pharma, Inc. (OYST) | 21-Dec-21 | Acquisition (other) | 51,556 | -- | -- | 1% 4.06M to 4.11M | |
| 23-Dec-21 4:40 PM View: | Oyster Point Pharma, Inc. (OYST) | 21-Dec-21 | Disposition (other) Duplicate | 51,556 | -- | -- | (1%) 4.11M to 4.06M | |
| 23-Dec-21 4:40 PM View: | Oyster Point Pharma, Inc. (OYST) | 21-Dec-21 | Disposition (other) | 201,474 | -- | -- | (5%) 4.06M to 3.86M | |
| 20-Oct-21 4:38 PM View: | Oyster Point Pharma, Inc. (OYST) | 18-Oct-21 | Market Sale (Planned) Duplicate | 550,000 | $14.84 | $8,160,740.00 | (12%) 4.61M to 4.06M | 16% |
| 01-Jul-21 7:01 PM View: | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 12,343,700 | -- | -- | 522% 2.36M to 14.71M | |
| 01-Jul-21 7:01 PM View: | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 1,527,720 | -- | -- | 10% 14.71M to 16.24M | |
| 01-Jul-21 7:01 PM View: | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Purchase Duplicate | 180,000 | $17.00 | $3,060,000.00 | 1% 16.24M to 16.42M | |
| 30-Jun-21 5:00 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion | 6,515,870 | -- | -- | 2300% 283.25K to 6.8M | |
| 30-Jun-21 5:00 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion | 1,940,040 | -- | -- | 29% 6.8M to 8.74M | |
| 30-Jun-21 5:00 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase | 157,895 | $19.00 | $3,000,000.00 | 2% 8.74M to 8.9M | |
| 23-Jun-21 4:30 PM View: | Century Therapeutics, Inc. (IPSC) | 22-Jun-21 | Conversion | 9,936,010 | -- | -- | 333% 2.98M to 12.92M | |
| 23-Jun-21 4:30 PM View: | Century Therapeutics, Inc. (IPSC) | 22-Jun-21 | Conversion | 614,095 | -- | -- | 5% 12.92M to 13.53M | |
| 23-Jun-21 4:30 PM View: | Century Therapeutics, Inc. (IPSC) | 22-Jun-21 | Private Purchase | 100,000 | $20.00 | $2,000,000.00 | < 1% 13.53M to 13.63M | |
| 14-May-21 4:45 PM View: | Oyster Point Pharma, Inc. (OYST) | 12-May-21 | Acquisition (other) Duplicate | 82,486 | -- | -- | 2% 4.93M to 5.02M | |
| 14-May-21 4:45 PM View: | Oyster Point Pharma, Inc. (OYST) | 12-May-21 | Disposition (other) Duplicate | 404,844 | -- | -- | (8%) 5.02M to 4.61M | |
| 30-Mar-21 7:05 PM View: | Oyster Point Pharma, Inc. (OYST) | 26-Mar-21 | Acquisition (other) Duplicate | 82,491 | -- | -- | 2% 5.26M to 5.34M | |
| 30-Mar-21 7:05 PM View: | Oyster Point Pharma, Inc. (OYST) | 26-Mar-21 | Disposition (other) Duplicate | 404,849 | -- | -- | (8%) 5.34M to 4.93M | |
| 19-Feb-21 5:16 PM View: | Oyster Point Pharma, Inc. (OYST) | 17-Feb-21 | Acquisition (other) Duplicate | 12,107 | -- | -- | < 1% 5.58M to 5.59M | |
| 19-Feb-21 5:16 PM View: | Oyster Point Pharma, Inc. (OYST) | 17-Feb-21 | Disposition (other) Duplicate | 12,107 | -- | -- | (< 1%) 5.59M to 5.58M | |
| 19-Feb-21 5:16 PM View: | Oyster Point Pharma, Inc. (OYST) | 17-Feb-21 | Disposition (other) | 325,000 | -- | -- | (6%) 5.58M to 5.26M | |
| 16-Dec-20 7:04 PM View: | Black Diamond Therapeutics,... (BDTX) | 14-Dec-20 | Acquisition (other) Duplicate | 617 | -- | -- | < 1% 6.45M to 6.45M | |
| 16-Dec-20 7:04 PM View: | Black Diamond Therapeutics,... (BDTX) | 14-Dec-20 | Disposition (other) Duplicate | 617 | -- | -- | (< 1%) 6.45M to 6.45M | |
| 16-Dec-20 7:04 PM View: | Black Diamond Therapeutics,... (BDTX) | 14-Dec-20 | Disposition (other) Duplicate | 20,784 | -- | -- | (< 1%) 6.45M to 6.43M | |
| 01-Dec-20 7:13 PM View: | Black Diamond Therapeutics,... (BDTX) | 30-Nov-20 | Acquisition (other) | 930 | -- | -- | < 1% 6.49M to 6.49M | |
| 01-Dec-20 7:13 PM View: | Black Diamond Therapeutics,... (BDTX) | 30-Nov-20 | Disposition (other) Duplicate | 930 | -- | -- | (< 1%) 6.49M to 6.49M | |
| 01-Dec-20 7:13 PM View: | Black Diamond Therapeutics,... (BDTX) | 30-Nov-20 | Disposition (other) | 31,175 | -- | -- | (< 1%) 6.49M to 6.46M | |
| 01-Dec-20 7:13 PM View: | Black Diamond Therapeutics,... (BDTX) | 30-Nov-20 | Sale (Planned) | 10,393 | $33.15 | $344,513.00 | (< 1%) 6.46M to 6.45M | |
| 01-Dec-20 7:13 PM View: | Black Diamond Therapeutics,... (BDTX) | 27-Nov-20 | Acquisition (other) | 14,677 | -- | -- | < 1% 6.88M to 6.9M | |
| 01-Dec-20 7:13 PM View: | Black Diamond Therapeutics,... (BDTX) | 27-Nov-20 | Disposition (other) | 394,000 | -- | -- | (6%) 6.9M to 6.51M | |
| 01-Dec-20 7:13 PM View: | Black Diamond Therapeutics,... (BDTX) | 27-Nov-20 | Disposition (other) Duplicate | 14,677 | -- | -- | (< 1%) 6.51M to 6.49M | |
| 25-Nov-20 4:49 PM View: | Black Diamond Therapeutics,... (BDTX) | 23-Nov-20 | Acquisition (other) | 23,599 | -- | -- | < 1% 7.65M to 7.67M | |
| 25-Nov-20 4:49 PM View: | Black Diamond Therapeutics,... (BDTX) | 23-Nov-20 | Disposition (other) | 476,659 | -- | -- | (6%) 7.67M to 7.19M | |
| 25-Nov-20 4:49 PM View: | Black Diamond Therapeutics,... (BDTX) | 23-Nov-20 | Disposition (other) | 308,853 | -- | -- | (4%) 7.19M to 6.88M | |
| 23-Nov-20 4:41 PM View: | Black Diamond Therapeutics,... (BDTX) | 19-Nov-20 | Sale (Planned) | 15,163 | $33.01 | $500,531.00 | (< 1%) 7.78M to 7.76M | |
| 23-Nov-20 4:41 PM View: | Black Diamond Therapeutics,... (BDTX) | 19-Nov-20 | Sale (Planned) | 114,854 | $33.01 | $3,791,330.00 | (1%) 7.76M to 7.65M | |
| 19-Nov-20 9:19 PM View: | Black Diamond Therapeutics,... (BDTX) | 18-Nov-20 | Sale (Planned) | 63 | $33.09 | $2,084.91 | (< 1%) 7.78M to 7.78M | |
| 19-Nov-20 9:19 PM View: | Black Diamond Therapeutics,... (BDTX) | 18-Nov-20 | Sale (Planned) | 473 | $33.09 | $15,653.40 | (< 1%) 7.78M to 7.78M | |
| 19-Nov-20 9:19 PM View: | Black Diamond Therapeutics,... (BDTX) | 17-Nov-20 | Sale (Planned) | 489 | $33.05 | $16,161.40 | (< 1%) 7.78M to 7.78M | |
| 19-Nov-20 9:19 PM View: | Black Diamond Therapeutics,... (BDTX) | 17-Nov-20 | Sale (Planned) | 3,705 | $33.05 | $122,450.00 | (< 1%) 7.78M to 7.78M |